Posted inPolitics & Elections, Syndicated

Vivek Ramaswamy’s crusade to change FDA could boost biotech, and himself

By Daniel Gilbert · The Washington Post (c) 2024 Vivek Ramaswamy, an outspoken ex-biotech executive turned fierce critic of the industry’s main regulator, is now in a position to reshape the agency he derides as the “Failed Drug Administration” in ways that could benefit him personally. Newly tapped by President-elect Donald Trump to co-lead an initiative […]

Posted inPolitics & Elections, Syndicated

Vivek Ramaswamy’s crusade to change FDA could boost biotech, and himself

By Daniel Gilbert · The Washington Post (c) 2024 Vivek Ramaswamy, an outspoken ex-biotech executive turned fierce critic of the industry’s main regulator, is now in a position to reshape the agency he derides as the “Failed Drug Administration” in ways that could benefit him personally. Newly tapped by President-elect Donald Trump to co-lead an initiative […]